dexmedetomidine has been researched along with proline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Cheng, Z; Feng, J; Li, A; Qian, H; Wu, Y; Xiao, H; Yan, F; Yang, Q; Zhang, X; Zhao, Z | 1 |
2 other study(ies) available for dexmedetomidine and proline
| Article | Year |
|---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Dexmedetomidine inhibits inflammatory reaction in the hippocampus of septic rats by suppressing NF-κB pathway.
Topics: Animals; Anti-Inflammatory Agents; Dexmedetomidine; Disease Models, Animal; Drug Synergism; Gene Expression Regulation; Hippocampus; Injections, Intraperitoneal; Interleukin-6; Lipopolysaccharides; Neuroprotective Agents; NF-kappa B; Proline; Rats; Rats, Sprague-Dawley; Sepsis; Signal Transduction; Thiocarbamates; Tumor Necrosis Factor-alpha | 2018 |